Silverback Therapeutics, Inc. (NASDAQ:SBTX – Get Free Report)’s stock price shot up 0.8% during mid-day trading on Tuesday . The stock traded as high as $13.31 and last traded at $13.05. 1,265,037 shares were traded during trading, an increase of 274% from the average session volume of 337,931 shares. The stock had previously closed at $12.95.
Silverback Therapeutics Stock Performance
The company has a fifty day simple moving average of $11.69 and a 200 day simple moving average of $9.89. The stock has a market capitalization of $535.82 million, a price-to-earnings ratio of -6.14 and a beta of 0.60.
Silverback Therapeutics Company Profile
Silverback Therapeutics, Inc, a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver.
Featured Stories
- Five stocks we like better than Silverback Therapeutics
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
- Consumer Staples Stocks, Explained
- How the Fed’s Rate Cut Could Supercharge These 3 ETFs
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Microsoft Stock: 3 Reasons It’s Ready to Crush Q4
Receive News & Ratings for Silverback Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silverback Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
